Track topics on Twitter Track topics that are important to you
Latest news articles in the life-science, healthcare, medical device, biotechnology and pharmaceuticals sectors.
Watch a pee wee football team take a dance break in between — and during — plays. read more
David SalazarA $106 billion acquisition of SABMiller might be on the horizon. read more
David SalazarThe winners of the 2015 Good Neighbor Pharmacy NCPA Pruitt-Schutte Student Business Plan Competition were announced this weekend at the NCPA’s annual convention. read more
David SalazarRather than comparing one gene to one drug, DNA4Life’s report looks at 12 common genes that can have an affect on how a patient responds to drugs. read more
David Salazarread more
Michael JohnsenHispanics over 50 represent 10% of their age cohort in 2015 and are expected to grow to 42 million, or 24% by 2060. read more
Kroger has announced that it had added transgender health benefits to one of the company’s health insurance plans, according to Forbes. "Beginning January 1, 2016, medical procedures including surgery and drug therapy for gender reassignment will be covered up to a $100,000 lifetime maximum for eligible associates and their dependents,” the company wrote on their employe...
Michael JohnsenThe first Bluetooth enabled thermometer from a major brand, the Vicks SmartTemp makes tracking multiple kids' temperatures easier with a companion app available for Android or Apple devices. read more
Michael JohnsenThe Deals store conversions are expected to be completed by the end of July 2016. read more
The National Institute for Health and Care Excellence has set up a paid-for service to help companies achieve quicker approval for their products.
Michael Johnsen All funds raised will be donated to the American Diabetes Association in support of its mission to prevent and cure diabetes and to improve the lives of all people affected by diabetes. read more
Determining the real worth of a treatment means more than just measuring the effect on clinical symptoms.
The European medicines safety watchdog is reviewing existing national and international patient registries in an attempt to improve and standardise data collection.
Michael JohnsenThe collaboration includes webinars and community events for the pharmacy community, a resource guide available through NCPA and access to navigators and assistors. read more
Decreases in body mass index in children treated with metformin could be partly due to increases in height, according to the results of a new study.
Michael JohnsenCVS Health's 2016 SilverScript prescription drug insurance plans earned an overall 4-star rating from the Centers for Medicare and Medicaid Services in part for their high quality, clinical outcomes and customer service. read more
Michael JohnsenIndependents are very much community focused two out of every three independent pharmacists are involved with local organizations, like Boy Scouts or the local Parent Teacher Association. read more
Michael JohnsenIndependents are very much community focused - two out of every three independent pharmacists are involved with local organizations, like Boy Scouts or the local Parent Teacher Association. read more
Shire has announced that the United States Food and Drug Administration (FDA) has granted fast track designation for the investigation of Cinryze (C1 esterase inhibitor [human]) for intravenous administration in subjects with Antibody Mediated Rejection (AMR) in renal transplant procedures. Cinryze is being studied as an adjunct treatment to Donor Specific Antibodies (DSA) reduction therapy in kid...
MedImmune has joined the Human Vaccines Project, which aims to accelerate the research and development of vaccines and immunotherapies for infectious diseases and cancer. The Human Vaccines Project is based at the International AIDS Vaccine Initiative (IAVI)- a new public-private partnership seeking to transform the future of global disease prevention and treatment by solving the primary scientifi...
David SalazarAurobindo’s latest approval is for an antipsychotic meant to treat bipolar disorder and schizophrenia. read more
Michael Johnsenread more
Novartis is to invest an extra $15 million into Israeli stem cell therapy developer Gamida Cell, adding an additional 2.5% to its existing 15% shareholding. The Swiss company paid $35 million for the initial 15% stake last year and also has a $600 buyout option that it may exercise until 2016, although it has opted not to on two occasions thus far. The new investment- an initial $5 million, plus p...
Diagnosing insomnia, sleep-related breathing disorders and central disorders of hypersomnolence.
Unity Scientific announces that Union Park Capital has acquired the company. Unity Scientific will continue operating under the same Unity brand and from the same manufacturing and technology center in Brookfield, CT. Majority owner Joseph Platano will retire as Chairman of the company, while Doug Evans will continue as President. “Unity is an exceptionally strong company,” says Morgan...